Skip to main content
Log in

Risk-stratified screening for melanoma may be cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 British pounds

Reference

  • Wilson ECF, et al. A Modeling Study of the Cost Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom. Value in Health : 11 Apr 2018. Available from: URL: https://doi.org/10.1016/j.jval.2017.11.009

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk-stratified screening for melanoma may be cost effective. PharmacoEcon Outcomes News 802, 25 (2018). https://doi.org/10.1007/s40274-018-4916-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4916-0

Navigation